The third quarter ended December 2024 witnessed certain stake increases by LIC in multiple companies.
Market movement to be limited in coming quarter; be neutral on pharma: Amit Khurana
Amit Khurana of Dolat Capital anticipates limited market movement in the coming quarter due to headwinds, suggesting a cooling period before renewed buying. Upside potential